全文获取类型
收费全文 | 38926篇 |
免费 | 2567篇 |
国内免费 | 139篇 |
专业分类
耳鼻咽喉 | 412篇 |
儿科学 | 864篇 |
妇产科学 | 759篇 |
基础医学 | 4640篇 |
口腔科学 | 994篇 |
临床医学 | 4050篇 |
内科学 | 8150篇 |
皮肤病学 | 410篇 |
神经病学 | 3289篇 |
特种医学 | 1298篇 |
外国民族医学 | 1篇 |
外科学 | 6709篇 |
综合类 | 541篇 |
一般理论 | 26篇 |
预防医学 | 3148篇 |
眼科学 | 1197篇 |
药学 | 2467篇 |
中国医学 | 39篇 |
肿瘤学 | 2638篇 |
出版年
2023年 | 180篇 |
2022年 | 311篇 |
2021年 | 718篇 |
2020年 | 439篇 |
2019年 | 636篇 |
2018年 | 773篇 |
2017年 | 557篇 |
2016年 | 654篇 |
2015年 | 772篇 |
2014年 | 1121篇 |
2013年 | 1716篇 |
2012年 | 2466篇 |
2011年 | 2560篇 |
2010年 | 1456篇 |
2009年 | 1362篇 |
2008年 | 2336篇 |
2007年 | 2403篇 |
2006年 | 2402篇 |
2005年 | 2582篇 |
2004年 | 2493篇 |
2003年 | 2284篇 |
2002年 | 2174篇 |
2001年 | 287篇 |
2000年 | 229篇 |
1999年 | 378篇 |
1998年 | 511篇 |
1997年 | 412篇 |
1996年 | 350篇 |
1995年 | 343篇 |
1994年 | 280篇 |
1993年 | 266篇 |
1992年 | 217篇 |
1991年 | 192篇 |
1990年 | 159篇 |
1989年 | 155篇 |
1988年 | 148篇 |
1987年 | 160篇 |
1986年 | 148篇 |
1985年 | 178篇 |
1984年 | 264篇 |
1983年 | 259篇 |
1982年 | 370篇 |
1981年 | 332篇 |
1980年 | 308篇 |
1979年 | 153篇 |
1978年 | 194篇 |
1977年 | 201篇 |
1976年 | 191篇 |
1975年 | 149篇 |
1973年 | 149篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
This study examined whether relationships between anger expression, hostility, social evaluative anxiety, and a presumed mechanism for coronary heart disease development, cardiovascular reactivity (CVR) to stress, are moderated by stress situation and gender and whether such relationships are attenuated by inadequate assessments. Subjects (47 men, 47 women) were assigned randomly to either a Harassment or a Social Evaluation condition, under which they performed a reaction time task. SBP, DBP, and HR measures were recorded during baseline and task. Multiple regression analyses indicated that expressed anger was related to CVR only among men in the Harassment condition; that hostile men who express anger showed the most CVR across situations, and that the traits assessed here did not predict CVR among women. Results suggest that assessments of coronary-risk and interventions to reduce risk may need to take into account attitudes, styles of emotional expression, environmental factors, and gender.This research was supported in part by an NIMH predoctoral fellowship (F31MH09836) awarded to John W. Burns and by a grant from the American Heart Association (89-01-3G) awarded to Edward S. Katkin. 相似文献
92.
93.
94.
Allen Cato III Linda E. Gustavson Jiang Qian Tawakol El-Shourbagy Edward A. Kelly 《Epilepsia》1998,39(1):43-47
Summary: Purpose: We wished to determine the effect of renal impairment on the pharmacokinetics and tolerability of the new antiepileptic drug tiagabine (TGB).
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
95.
96.
97.
Edward McAuley 《Journal of behavioral medicine》1993,16(1):103-113
The role played by exercise self-efficacy in the maintenance of exercise participation of previously sedentary middle-aged adults 4 months after the termination of a formal exercise program is reported. Correlational and multiple regression analyses examined the influence of self-efficacy, physiological (aerobic capacity, sex, body composition), and behavioral (past exercise frequency and intensity) parameters in the maintenance of exercise participation. Self-efficacy significantly predicted exercise behavior at follow-up when controlling for biological and behavioral influences. Aerobic capacity, exercise efficacy, and exercise behavior in combination were significantly related to current energy expenditure in aerobic physical activity. The discussion focuses on the need to examine the impact of different correlates of exercise behavior at different stages of the exercise process.This project was funded by Grant AG07907 from the National Institute on Aging. 相似文献
98.
Superior mesenteric artery is more important than inferior mesenteric artery in maintaining colonic mucosal perfusion and integrity in rats 总被引:1,自引:0,他引:1
Dr. Felix W. Leung MD Kenny C. Su MD Jose M. Pique MD Gerard Thiefin MD Edward Passaro Jr MD Paul H. Guth MD 《Digestive diseases and sciences》1992,37(9):1329-1335
Mucosal hemodynamics (by reflectance spectrophotometry) and mucosal damage (by histologic examination) following acute colonic ischemia were evaluated in different anatomic locations in the colon of anesthetized rats. The reflectance spectrophotometer provides an index of mucosal hemoglobin concentration (IHB) and an index of oxygen saturation of hemoglobin (ISO2). The patterns of ischemia without congestion (IHB, ISO2) during superior mesenteric artery occlusion, and ischemia with congestion (IHB, ISO2) during portal vein occlusion, previously demonstrated in the stomach and duodenum, are also applicable to the colon. The significant linear correlations between changes (as percent of baseline) in IHB, ISO2, and hydrogen gas clearance suggest that changes in these indices are adequate indicators of changes in colonic mucosal perfusion. Superior mesenteric artery ligation produced significant reductions in both indices, and an increase in damage in the mucosa of the cecum, transverse colon, splenic flexure, and left colon, but not the rectum. Inferior mesenteric artery ligation produced only slight reduction in these indices and minimal damage only in the mucosa of the splenic flexure. These results support the hypothesis that the superior mesenteric artery is more important than the inferior mesenteric artery in maintaining colonic perfusion and colonic mucosal integrity in the rat.Supported by the American Society for Gastrointestinal Endoscopy Career Development Award (H850208, H870212), Veterans Administration Medical Research Funds; and in part by research grants (0162-01, 0162-02; 0291-01) from the Smokeless Tobacco Research Council, Inc.; and by funds provided by the Cigarette and Tobacco Surtax Fund of the State of California through the Tobacco Related Disease Research Program of the University of California. 相似文献
99.
Steven C. Cramer Roy H. Rhodes Edward M. Acton Zoltán A. Tökés 《Cancer chemotherapy and pharmacology》1989,23(2):71-75
Summary The highly lipophilic cyanomorpholinyl adriamycin (CMA) is the most potent antineoplastic anthracycline yet described. CNS distribution and toxicity were examined after i.v. administration of CMA to mice. At doses 0.1 mg/kg, a neurotoxic syndrome including ataxia, hypokinesia, and tremors appeared. At doses of 0.05 mg/kg, which have been reported to be antineoplastic, no neurotoxicity was observed. On histopathologic examination, no changes were observed in the brain, spinal cord, or dorsal root ganglia. Unlike adriamycin (ADR), which rapidly appears in the nuclei of several tissues, CMA showed no fluorescence, suggesting a different cellular microcompartmentalization. The i.d. injection of CMA disclosed a 200-fold increase in toxicity compared with that of adriamycin. In comparisons of CMA and ADR, neurotoxicity and cardiotoxicity occurred equally only at higher doses; however, the dermatotoxicity and antineoplastic activity of CMA were increased several hundred-fold. 相似文献
100.